L-Erdosteine
Product Description
Daebong LS
-
Country/Region:Korea, Republic Of
-
On CPHI since:2021
-
Employees:250 - 499
Company types
Categories
Specifications
Daebong LS
-
Country/Region:Korea, Republic Of
-
On CPHI since:2021
-
Employees:250 - 499
Company types
More Products from Daebong LS (2)
-
Product Azilsartan new salt
New salt improved drug and innovative manufacturing method. Manufacturing method of Azilsartan using eco-friendly solvents. License to implement the manufacturing method based on patents. - Technology transfer with patent -
Product Efinaconazole co-crystal
First-in-the world oral delivery system for antifungal therapies, designed for improved, dosing and patient convenience. Global patents. S. Korea, Japan, China, US, EU, and India - covering composition, manufacturing method, sustainable production, and formulation. - Technology transfer with patent
Daebong LS resources (2)
-
News Daebong Life Science to Showcase Innovative API Developments at CPhI Frankfurt 2025
Daebong LS is pleased to announce its participation in CPhI Frankfurt 2025 on October 28th, where the company will engage in a series of B2B meetings with global partners.
During the event, Daebong LS will highlight its latest research achievements, including:
Efinaconazole Co-crystal
L-Erdosteine
Novel Salt of Azilsartan
Through these presentations, Daebong LS aims to explore opportunities for technology transfer and strengthen collaborations with leading companies in the pharmaceutical industry.
As an active developer of innovative active pharmaceutical ingredients (APIs), Daebong continues to expand its global partnerships and contribute to advancing healthcare solutions.
-
Brochure R&D Center
New R&D Center in Songdo